R&D Changing Faces – Pharma and biotech hires for June 2025 Read on for some of the key appointments of last month. Bristol Myers Squibb adds two executive leaders.
R&D Immune mediation, B-cell depletion, and female leadership – ... In a new pharmaphorum podcast, Aoife Brennan, CEO of Climb Bio, discusses the treatment of immune-mediated diseases.
R&D Bridging science and care: Advancing biomedical innovation As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help.
R&D Medicine’s blind spot: How clinical trials are failing women From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
R&D What to do when your grant application fails All hope should not be lost and an unsuccessful application doesn’t always mark the end of the road.
News ESMO26: Sac-TMT delivers the goods in PD-L1-negative NSCLC Kelun and MSD's TROP2-directed ADC, sac-TMT, reduced the risk of disease progression or death by 51% when used first-line in PD-L1-negative NSCLC.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
